Please assess the completion status of the following clinical trial:

Trial Title: Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* ASA status I-II~* aged 2-5 yr~* Undergoing unilateral orchiopexy/inguinal hernia repair~Exclusion Criteria:~* Hypersensitivity to any local anesthetics~* Patient has history of allergy, intolerance, or reaction to dexmedetomidine~* Infections at puncture sites~* Bleeding diathesis~* Preexisting neurological disease~* Diabetes mellitus~* Children with uncorrected cardiac lesions~* Children with heart block or liver impairment

- Gender: MALE
- Minimum Age: 2 Years
- Maximum Age: 5 Years
- Healthy Volunteers: f

Study Arms:
- Caudal Dexmedetomidine (Type: EXPERIMENTAL): Caudal: Levobupivacaine 0.25% 1ml/kg and dexmedetomidine 1µg/kg~Intravenous: 10 ml normal saline~Anesthesia was induced and maintained with sevoflurane
- Intravenous Dexmedetomidine (Type: EXPERIMENTAL): Caudal: Levobupivacaine 0.25% 1ml/kg~Intravenous: dexmedetomidine 1µg/kg~Anesthesia was induced and maintained with sevoflurane
- Placebo (Type: PLACEBO_COMPARATOR): Caudal: Levobupivacaine 0.25% 1ml/kg~Intravenous: 10 ml normal saline~Anesthesia was induced and maintained with sevoflurane

Based on this trial design, predict the completion outcome and termination type (if applicable).